Patent details

EN | LT

LT - Prisijungiantys baltymai, įskaitant antikūnus, antikūno dariniai ir antikūno fragmentai, kurie specifiškai suriša CD154, ir jų panaudojimas

EN - BINDING PROTEINS, INCLUDING ANTIBODIES, ANTIBODY DERIVATIVES AND ANTIBODY FRAGMENTS, THAT SPECIFICALLY BIND CD154 AND USES THEREOF

Legal status

Patent in force

Claims | Licences/Sublicenses

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07K 16/28	(2006.01)

European patent
(11)	Number of the document	2125894
(13)	Kind of document	T
(96)	European patent application number	08742182.2
	Date of filing the European patent application	2008-03-21
(97)	Date of publication of the European application	2009-12-02
(45)	Date of publication and mention of the grant of the patent	2018-12-19
(46)	Date of publication of the claims translation	2019-03-25

PCT application
(86)	Number	PCT/US2008/003735
	Date	2008-03-21

PCT application publication
(87)	Number	WO 2008/118356
	Date	2008-10-02

Inventors
(72)	BURKLY, Linda C., US FERRANT-ORGETTAS, Janine L., US GARBER, Ellen A., US HSU, Yen-ming, US SU, Lihe, US TAYLOR, Frederick R., US ADAMS, Ralph, GB BROWN, Derek Thomas, GB POPPLEWELL, Andrew George, GB ROBINSON, Martyn Kim, GB SHOCK, Anthony, GB TYSON, Kerry Louise, GB

Grantee
(73)	Biogen MA Inc., 225 Binney Street, Cambridge, MA 02142, US UCB Biopharma SRL, Allée de la Recherche 60, 1070 Brussels, BE

Attorney or representative
(74)	Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT

Title
(54)	Prisijungiantys baltymai, įskaitant antikūnus, antikūno dariniai ir antikūno fragmentai, kurie specifiškai suriša CD154, ir jų panaudojimas
	BINDING PROTEINS, INCLUDING ANTIBODIES, ANTIBODY DERIVATIVES AND ANTIBODY FRAGMENTS, THAT SPECIFICALLY BIND CD154 AND USES THEREOF

Last renewal fee
	Payment date	Validity (years)	Amount
	2026-02-23	19	347.00 EUR

Next renewal fee
	2027-03-21